Pfizer(PFE Quote) CEO Jeff Kindler says the drug giant is open to acquisitions large and small, so let the deal-making guessing game begin.
Might Pfizer buy Amgen(AMGN Quote) or Gilead Sciences(GILD Quote) to boost its biotech street credibility? How about another Big Pharma mega-merger with Bristol-Myers Squibb(BMY Quote) or Wyeth(WYE Quote)?
Kindler, in an interview with the Financial Times published Sunday, said Pfizer would consider a major acquisition as a way to improve the company's financial health. The "real goal is to grow revenues ... We are open to opportunities and constantly looking at those which are big, small and in between," Kindler told the paper. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,331.31 | 1,094.16 | 2,145.39 | 32.25 |
Oil *
77.19
|
|
DOWN
133.09
|
DOWN
16.47
|
DOWN
30.66
|
DOWN
0.54
|
10 Yr
3.22%
SPDR Gold
115.21
|
|
-1.27%
|
-1.48%
|
-1.41%
|
-1.65%
|
Data delayed 20 minutes |


Connect with TheStreet